相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PI3K/AKT/mTOR signaling in gastric cancer: Epigenetics and beyond
Sadegh Fattahi et al.
LIFE SCIENCES (2020)
Tannic acid-inspired paclitaxel nanoparticles for enhanced anticancer effects in breast cancer cells
Pallabita Chowdhury et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2019)
Shikonin derivatives for cancer prevention and therapy
Joelle C. Boulos et al.
CANCER LETTERS (2019)
Design, synthesis and biological evaluation of benzoylacrylic acid shikonin ester derivatives as irreversible dual inhibitors of tubulin and EGFR
Wen-Xue Sun et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
Deoxyshikonin isolated from Arnebia euchroma inhibits colorectal cancer by down-regulating the PI3K/Akt/mTOR pathway
Yuzhen Zhu et al.
PHARMACEUTICAL BIOLOGY (2019)
Acetylshikonin inhibits the migration and invasion of A375 cells by reversing EMT process via the PI3K/Akt/mTOR pathway
Shuang Jiang et al.
BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT (2019)
The Critical Role of PTEN/PI3K/AKT Signaling Pathway in Shikonin-Induced Apoptosis and Proliferation Inhibition of Chronic Myeloid Leukemia
Yu Chen et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Breast Cancer Epidemiology in Gulf Cooperation Council Countries: A Regional and International Comparison
Salman M. Albeshan et al.
CLINICAL BREAST CANCER (2018)
Design and characterization of α-lipoic acyl shikonin ester twin drugs as tubulin and PDK1 dual inhibitors
Hong-Yan Lin et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Shikonin exerts antitumor activity in Burkitt's lymphoma by inhibiting C-MYC and PI3K/AKT/mTOR pathway and acts synergistically with doxorubicin
Fan Ni et al.
SCIENTIFIC REPORTS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Synthesis and biological evaluation of novel Jiyuan Oridonin A-1,2,3-triazole-azole derivatives as antiproliferative agents
Yu Ke et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Discovery of (4-bromophenyl)(3-hydroxy-4-methoxyphenyl) methanone through upregulating hTERT induces cell apoptosis and ERS
Xiu Cheng et al.
CELL DEATH & DISEASE (2017)
Targeting the Akt/PI3K Signaling Pathway as a Potential Therapeutic Strategy for the Treatment of Pancreatic Cancer
Safieh Ebrahimi et al.
CURRENT MEDICINAL CHEMISTRY (2017)
Shikonin Derivative DMAKO-05 Inhibits Akt Signal Activation and Melanoma Proliferation
Yao-yao Yang et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2016)
Fascaplysin Induces Caspase Mediated Crosstalk Between Apoptosis and Autophagy Through the Inhibition of PI3K/AKT/mTOR Signaling Cascade in Human Leukemia HL-60 Cells
Suresh Kumar et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2015)
Role of PI3K/Akt/mTOR and MEK/ERK pathway in Concanavalin A induced autophagy in HeLa cells
Bibhas Roy et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2014)
Receptor-Defined Subtypes of Breast Cancer in Indigenous Populations in Africa: A Systematic Review and Meta-Analysis
Amanda Eng et al.
PLOS MEDICINE (2014)
Integration of Different -omics Technologies Identifies Inhibition of the IGF1R-Akt-mTOR Signaling Cascade Involved in the Cytotoxic Effect of Shikonin against Leukemia Cells
Benjamin Wiench et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)
Targeting triple-negative breast cancer: optimising therapeutic outcomes
K. Gelmon et al.
ANNALS OF ONCOLOGY (2012)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Deciphering the Role of PI3K/Akt/mTOR Pathway in Breast Cancer Biology and Pathogenesis
Priscilla F. McAuliffe et al.
CLINICAL BREAST CANCER (2010)
SYUNZ-16, a newly synthesized alkannin derivative, induces tumor cells apoptosis and suppresses tumor growth through inhibition of PKB/AKT kinase activity and blockade of AKT/FOXO signal pathway
Rong Deng et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Prognostic markers in triple-negative breast cancer
Emad A. Rakha et al.
CANCER (2007)
Shikonin, a component of Chinese herbal medicine, inhibits chemokine receptor function and suppresses human immunodeficiency virus type 1
X Chen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
分享论文
